Status of vaccine procurement by pvt vaccination centres worrying: Centre

Union Health Ministry on Wednesday reviewed the status and the progress of vaccine procurement by private COVID vaccination centres.

Vaccine production
ANI General News
1 min read Last Updated : Jul 14 2021 | 7:26 PM IST

Union Health Ministry on Wednesday reviewed the status and the progress of vaccine procurement by private COVID vaccination centres.

The review meeting was chaired by Union Health Secretary Rajesh Bhushan. Health Secretaries and senior immunization officials of 15 States/ UTs, namely Uttar Pradesh, Madhya Pradesh, Rajasthan, Odisha, Telangana, Arunachal Pradesh, Karnataka, Kerala, Tamil Nadu, Maharashtra, Gujarat, West Bengal, Delhi, Punjab, and Haryana attended the meeting.

Representatives from the two Covid vaccine manufacturers, Bharat Biotech and Serum Institute of India, were also present.

States were, once again, informed about the usage of the Co-WIN platform as the backend management tool for order placements.

The Union Health Secretary termed the slow pace of vaccination through the Private Covid Vaccination Centres (PCVCs) as a 'cause of serious worry'.

He also highlighted the areas of concern and gave his suggestions for the same.

Mentioning the slow pace of vaccination in private centres, the centre advised the states to review status and progress on vaccine procurement by them on a daily basis.

The centre has organized five regional workshops to orient nodal officers of the states and private centers for placing orders on Co-Win and the payment for the quantum of doses.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineIndia vaccinationHealth Ministry

First Published: Jul 14 2021 | 7:26 PM IST

Next Story